These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25547350)

  • 1. Effect of reduced oxygen on the antifungal susceptibility of clinically relevant aspergilli.
    Binder U; Maurer E; Lackner M; Lass-Flörl C
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1806-10. PubMed ID: 25547350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential fungicidal activities of amphotericin B and voriconazole against Aspergillus species determined by microbroth methodology.
    Meletiadis J; Antachopoulos C; Stergiopoulou T; Pournaras S; Roilides E; Walsh TJ
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3329-37. PubMed ID: 17576838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breakpoints for antifungal agents: an update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp.
    Arendrup MC; Cuenca-Estrella M; Lass-Flörl C; Hope WW
    Drug Resist Updat; 2013 Dec; 16(6):81-95. PubMed ID: 24618110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A colorimetric and spectrophotometric method for in vitro susceptibility testing of Aspergillus species against caspofungin.
    Te Dorsthorst DT; Zwaaftink RB; Rijs AJ; Meletiadis J; Verweij PE
    Med Mycol; 2007 Jun; 45(4):351-5. PubMed ID: 17510858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamics and pharmacokinetics of antifungals for treatment of invasive aspergillosis.
    Bellmann R
    Curr Pharm Des; 2013; 19(20):3629-47. PubMed ID: 23278532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal activity of statins against Aspergillus species.
    Qiao J; Kontoyiannis DP; Wan Z; Li R; Liu W
    Med Mycol; 2007 Nov; 45(7):589-93. PubMed ID: 18033614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hypoxic conditions on in vitro susceptibility testing of amphotericin B, itraconazole and micafungin against Aspergillus and Candida.
    Warn PA; Sharp A; Guinea J; Denning DW
    J Antimicrob Chemother; 2004 May; 53(5):743-9. PubMed ID: 15044422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the Sensititre YeastOne and CLSI M38-A2 Microdilution Methods in Determining the Activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species.
    Wang HC; Hsieh MI; Choi PC; Wu CJ
    J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30093391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses.
    Öz Y; Özdemir HG; Gökbolat E; Kiraz N; Ilkit M; Seyedmousavi S
    Mycopathologia; 2016 Apr; 181(3-4):225-33. PubMed ID: 26612621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic effects of simulated standard doses of antifungal drugs against Aspergillus species in a new in vitro pharmacokinetic/pharmacodynamic model.
    Meletiadis J; Al-Saigh R; Velegraki A; Walsh TJ; Roilides E; Zerva L
    Antimicrob Agents Chemother; 2012 Jan; 56(1):403-10. PubMed ID: 22064546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of clinical strains of Aspergillus terreus complex: molecular identification and antifungal susceptibility to azoles and amphotericin B.
    Escribano P; Peláez T; Recio S; Bouza E; Guinea J
    Clin Microbiol Infect; 2012 Feb; 18(2):E24-6. PubMed ID: 22128886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental efficacy of anidulafungin against Aspergillus terreus species complex.
    Sanchis M; Capilla J; Mayayo E; Pastor FJ; Guarro J
    Med Mycol; 2015 Aug; 53(6):630-5. PubMed ID: 25980004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Aspergillus terreus infections: a clinical problem not yet resolved.
    Pastor FJ; Guarro J
    Int J Antimicrob Agents; 2014 Oct; 44(4):281-9. PubMed ID: 25190543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of disk diffusion method compared to broth microdilution for antifungal susceptibility testing of 3 echinocandins against Aspergillus spp.
    Martos AI; Martín-Mazuelos E; Romero A; Serrano C; González T; Almeida C; Puche B; Cantón E; Pemán J; Espinel-Ingroff A
    Diagn Microbiol Infect Dis; 2012 May; 73(1):53-6. PubMed ID: 22480568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Luliconazole, an alternative antifungal agent against Aspergillus terreus.
    Zargaran M; Taghipour S; Kiasat N; Aboualigalehdari E; Rezaei-Matehkolaei A; Zarei Mahmoudabadi A; Shamsizadeh F
    J Mycol Med; 2017 Sep; 27(3):351-356. PubMed ID: 28483449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydroorotate dehydrogenase inhibitor olorofim exhibits promising activity against all clinically relevant species within Aspergillus section Terrei.
    Lackner M; Birch M; Naschberger V; Grässle D; Beckmann N; Warn P; Gould J; Law D; Lass-Flörl C; Binder U
    J Antimicrob Chemother; 2018 Nov; 73(11):3068-3073. PubMed ID: 30351438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vitro Activities of Five Antifungal Drugs Against Opportunistic Agents of Aspergillus Nigri Complex.
    Badali H; Fakhim H; Zarei F; Nabili M; Vaezi A; Poorzad N; Dolatabadi S; Mirhendi H
    Mycopathologia; 2016 Apr; 181(3-4):235-40. PubMed ID: 26615417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activities of three licensed antifungal agents against spanish clinical isolates of Aspergillus spp.
    Gomez-Lopez A; Garcia-Effron G; Mellado E; Monzon A; Rodriguez-Tudela JL; Cuenca-Estrella M
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3085-8. PubMed ID: 14506013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspergillus species intrinsically resistant to antifungal agents.
    Van Der Linden JW; Warris A; Verweij PE
    Med Mycol; 2011 Apr; 49 Suppl 1():S82-9. PubMed ID: 20662634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of the echinocandin antifungal agent LY303,366 in comparison with itraconazole and amphotericin B against Aspergillus spp.
    Oakley KL; Moore CB; Denning DW
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2726-30. PubMed ID: 9756785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.